FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement
This article was originally published in The Tan Sheet
Executive Summary
FDA's warning letter to General Mills concerning cardiovascular health claims linked to Cheerios reflects a newly empowered agency and foreshadows aggressive regulatory activity to come, experts say